Base Editing: The Next Frontier in Genome Editing Technology
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights…
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights…
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO…
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions…
Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up…
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
Norway has not typically been an attractive region for biotech investors, so when Masha Strømme…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis…